Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been gaining popularity in managing diabetes mellitus (DM) owing to their effectiveness, cardioprotection, and convenient dosing [1]. The gene discussed is GLP1R; the disease is diabetes mellitus.